Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha

Details for Australian Patent Application No. 2008236562 (hide)

Owner EXELIXIS, INC.

Inventors Lamb, Peter; Matthews, David

Agent A J Park

Pub. Number AU-A-2008236562

PCT Pub. Number WO2008/124161

Priority 60/922,899 10.04.07 US

Filing date 9 April 2008

Wipo publication date 16 October 2008

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/4745 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/124161 Priority application(s): WO2008/124161

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008236563-Substrate-selective co-fermentation process

2008236558-Methods of degassing ophthalmic lens monomer mixtures